EFG Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.99M | Buy |
11,204
+2,072
| +23% | +$922K | 0.7% | 46 |
|
|
2025
Q1 | $4.43M | Sell |
9,132
-2,923
| -24% | -$1.42M | 0.74% | 37 |
|
|
2024
Q4 | $4.86M | Buy |
12,055
+3,964
| +49% | +$1.6M | 0.66% | 42 |
|
|
2024
Q3 | $3.76M | Sell |
8,091
-348
| -4% | -$162K | 0.63% | 38 |
|
|
2024
Q2 | $3.95M | Buy |
8,439
+1,138
| +16% | +$533K | 0.69% | 35 |
|
|
2024
Q1 | $3.05M | Sell |
7,301
-39
| -0.5% | -$16.3K | 0.53% | 61 |
|
|
2023
Q4 | $2.99M | Buy |
7,340
+2,502
| +52% | +$1.02M | 0.57% | 65 |
|
|
2023
Q3 | $1.68M | Sell |
4,838
-186
| -4% | -$64.7K | 0.4% | 87 |
|
|
2023
Q2 | $1.77M | Buy |
5,024
+722
| +17% | +$254K | 0.38% | 89 |
|
|
2023
Q1 | $1.35M | Sell |
4,302
-113
| -3% | -$35.6K | 0.3% | 119 |
|
|
2022
Q4 | $1.28M | Buy |
4,415
+451
| +11% | +$130K | 0.29% | 127 |
|
|
2022
Q3 | $1.15M | Buy |
3,964
+951
| +32% | +$275K | 0.27% | 128 |
|
|
2022
Q2 | $849K | Buy |
+3,013
| New | +$849K | 0.18% | 159 |
|